“…Previous studies have showed that GLP can mediate cytotoxicity in number of cancer cell lines including lung cancer, prostate cancer and breast cancer. Further studies showed that GLP programmed cell death through endothelial growth factor overexpression and tumor angiogenesis inhibition in highly metastatic mouse melanoma B16F10 cells (Sun et al, 2011), through endotoxin-induced intercellular cell adhesion molecule-1 (ICAM-1) upregulation in the neointima in mice (Liu et al, 2010), through cell differentiation and p53 activation in human monocytic leukemia THP-1 cells (Hsu et al, 2011), through activation of mitochondrial signaling pathway in MCF-7 breast cancer cells (Shang et al, 2011). GLP can also boost anticancer immunity by changing lymphocyte phenotype in H22 hepatoma mice (Zhou et al, 2009), by enhancing CD56 + NK-cell cytotoxicity in cord blood (Chien et al, 2004), by promoting the proliferation of B cells in mice (Jiang et al, 2003).…”